Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.

BMC cancer - 12 Jul 2022

Fairley Jennifer A, Cheetham Melanie H, Patton Simon J, Rouleau Etienne, Denis Marc, Dequeker Elisabeth M C, Schuuring Ed, van Casteren Kaat, Fenizia Francesca, Normanno Nicola, Deans Zandra C

Abstract excerpt

BACKGROUND: Circulating cell free DNA (cfDNA) testing of plasma for EGFR somatic variants in lung cancer patients is being widely implemented and with any new service, external quality assessment (EQA) is required to ensure patient safety. An international consortium, International Quality Network for Pathology (IQNPath), has delivered a second round of assessment to measure the accuracy of cfDNA testing for lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cell-Free Nucleic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gene Frequency

Share to Lung Cancer Diagnosis and Treatment

Share to Lung Cancer Treatments and Mutations

Share to Lung Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35820813
DOI: 10.1186/s12885-022-09849-x
PMCID: PMC9275131

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.PMID 35820813Read ↗

Results of a worldwide External Quality Assessment of cfDNA testing in Lung CancerSemantic proximity Read ↗

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.Semantic proximity Read ↗

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.Semantic proximity Read ↗

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.Semantic proximity Read ↗

Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.Semantic proximity Read ↗

Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA.Semantic proximity Read ↗

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.Semantic proximity Read ↗

External quality assessment for EGFR mutations in Italy: improvements in performances over the timeSemantic proximity Read ↗

What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.Semantic proximity Read ↗

Results of the UK NEQAS for Molecular Genetics reference sample analysis.Semantic proximity Read ↗

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.Semantic proximity Read ↗

A Comparative Study for Detection of EGFR Mutations in Plasma Cell-Free DNA in Korean Clinical Diagnostic Laboratories.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.